Can Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography Be Used As a Useful Method to Evaluate the Treatment Response to Neoadjuvant Therapy Combined With Sorafenib and Anti-VEGF in Children Diagnosed With Metastatical Bone Sarcoma?
IRANIAN JOURNAL OF PEDIATRICS, vol.26, no.2, 2016 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 26 Issue: 2
- Publication Date: 2016
- Doi Number: 10.5812/ijp.4008
- Journal Name: IRANIAN JOURNAL OF PEDIATRICS
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Keywords: Bone Tumors, Sorafenib, Anti-VEGF, PET, REFRACTORY SOLID TUMORS, PHASE-I TRIAL, ONCOLOGY GROUP, MURAMYL TRIPEPTIDE, PEDIATRIC-PATIENTS, EWING SARCOMA, F-18-FDG PET, OSTEOSARCOMA, DIFFERENTIATION, TEMOZOLOMIDE
- Open Archive Collection: AVESIS Open Access Collection
- Istanbul University Affiliated: No
Abstract
Background: The prognosis is still poor for patients with a metastatic bone tumor and new treatment approaches (anti-VEGF and tyrosine kinase inhibitors vs) are therefore needed.